• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东亚和东南亚人群中的化脓性汗腺炎:系统评价和荟萃分析。

Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis.

机构信息

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

出版信息

Int J Dermatol. 2021 Nov;60(11):e433-e439. doi: 10.1111/ijd.15671. Epub 2021 Jun 1.

DOI:10.1111/ijd.15671
PMID:34075575
Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that presents with recurrent inflammatory nodules and draining tunnels in the skin. Most HS studies have focused on Western populations, and the understanding of how HS characteristics differ in specific Asian ethnicities is poor. We conducted the first systematic review and meta-analysis to characterize HS patients from East and Southeast Asia. PubMed, Embase, and Ovid MEDLINE databases were searched from inception to June 12, 2020. English-language case-series, cross-sectional, observational, and randomized controlled trial studies investigating HS in East and Southeast Asian populations were screened by titles, abstracts, and articles in duplicate. Of 136 citations, 10 studies were included in the meta-analysis. Data on gender distribution, lesion distribution in the axilla and gluteal regions, and family history were extracted in duplicate. A random effects model was used for the meta-analysis. A total of 30,125 HS patients were included in the analysis. Most patients were male (66%, 95% CI = 60-72%). About half of Asian patients with HS develop lesions in the axilla (52%, 95% CI = 33-72%) and the buttocks (48%, 95% CI = 38-57%). Only a small subset had positive family history of HS (5%, 95% CI = 2-8%). We report an up-to-date characterization of HS in East and Southeast Asian populations and highlight differences in their Western counterparts. These results will hopefully improve understanding for how HS may manifest, lead to more personalized treatments for Asian patients with HS, and usher in a proper patient-centered approach to treating the disease.

摘要

化脓性汗腺炎(HS)是一种慢性炎症性皮肤病,表现为皮肤反复出现炎症性结节和引流窦道。大多数 HS 研究都集中在西方人群,而对特定亚洲种族 HS 特征的差异了解甚少。我们进行了首次系统评价和荟萃分析,以描述东亚和东南亚的 HS 患者。从创建到 2020 年 6 月 12 日,我们在 PubMed、Embase 和 Ovid MEDLINE 数据库中进行了检索。通过标题、摘要和文章对研究东亚和东南亚人群 HS 的英文病例系列、横断面、观察性和随机对照试验进行了双重筛选。在 136 条引文中有 10 项研究被纳入荟萃分析。对性别分布、腋窝和臀部病变分布以及家族史的数据进行了重复提取。荟萃分析采用随机效应模型。共纳入 30125 例 HS 患者。大多数患者为男性(66%,95%CI=60-72%)。约一半的亚洲 HS 患者在腋窝(52%,95%CI=33-72%)和臀部(48%,95%CI=38-57%)出现病变。仅有一小部分患者有 HS 的阳性家族史(5%,95%CI=2-8%)。我们报告了东亚和东南亚人群 HS 的最新特征,并强调了其与西方人群的差异。这些结果有望提高对 HS 可能表现的认识,为亚洲 HS 患者提供更个性化的治疗,并为治疗该疾病引入适当的以患者为中心的方法。

相似文献

1
Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis.东亚和东南亚人群中的化脓性汗腺炎:系统评价和荟萃分析。
Int J Dermatol. 2021 Nov;60(11):e433-e439. doi: 10.1111/ijd.15671. Epub 2021 Jun 1.
2
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.化脓性汗腺炎生活质量(HiSQOL)评分在成年化脓性汗腺炎患者真实世界应用中的验证。
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
3
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.一项定性访谈研究,探讨英国化脓性汗腺炎患者对治疗的看法和经历。
Br J Dermatol. 2025 Jun 20;193(1):85-92. doi: 10.1093/bjd/ljaf046.
4
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.使用比美吉珠单抗治疗化脓性汗腺炎的III期BE HEARD I和II试验的汇总数据,对化脓性汗腺炎生活质量(HiSQOL©)问卷进行心理测量学验证和解释阈值分析。
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
5
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
6
The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.化脓性汗腺炎体征和症状对生活质量的影响负担:系统评价和荟萃分析。
Int J Environ Res Public Health. 2021 Jun 22;18(13):6709. doi: 10.3390/ijerph18136709.
7
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Current Treatments and Future Directions for Hidradenitis Suppurativa: a Narrative Review of Completed and Ongoing Phase 3 Clinical Trials of Biologic Therapies.化脓性汗腺炎的当前治疗方法与未来方向:生物疗法已完成及正在进行的3期临床试验的叙述性综述
Dermatol Ther (Heidelb). 2025 Jul 18. doi: 10.1007/s13555-025-01487-y.
2
Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire.印度尼西亚化脓性汗腺炎患病率:一项横断面多中心研究及筛查问卷验证
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539705.
3
Prevalence of Hidradenitis Suppurativa in the Gulf Province of Papua New Guinea.
巴布亚新几内亚海湾省化脓性汗腺炎的患病率
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538422.
4
Prevalence of Hidradenitis Suppurativa in Hospital Kuala Lumpur, Malaysia: A Cross-Sectional Study.马来西亚吉隆坡医院化脓性汗腺炎的患病率:一项横断面研究。
Dermatology. 2025 Jul 7:1-7. doi: 10.1159/000539397.
5
Overburdened and Undertreated: Hidradenitis Suppurativa in Skin of Color.负担过重且治疗不足:有色人种皮肤中的化脓性汗腺炎
J Clin Aesthet Dermatol. 2024 Jul-Aug;17(7-8 Suppl 1):S38-S39.
6
Expression of nicastrin, NICD1, and Hes1 in NCSTN knockout mice: implications for hidradenitis suppurativa, Alzheimer's, and liver cancer.尼卡斯特林、NICD1和Hes1在NCSTN基因敲除小鼠中的表达:对化脓性汗腺炎、阿尔茨海默病和肝癌的影响。
Eur J Med Res. 2024 Dec 24;29(1):622. doi: 10.1186/s40001-024-02225-4.
7
Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.探究化脓性汗腺炎患者疾病历程中的种族和民族差异:欧洲和美国一项真实世界研究的结果
J Dermatol. 2024 Dec;51(12):1547-1558. doi: 10.1111/1346-8138.17386. Epub 2024 Oct 14.
8
New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials.化脓性汗腺炎表型与治疗反应的新见解:SUNSHINE和SUNRISE试验的探索性自动分析
J Eur Acad Dermatol Venereol. 2025 Aug;39(8):1410-1420. doi: 10.1111/jdv.20234. Epub 2024 Aug 5.
9
Recent advances in hidradenitis suppurativa: Role of race, genetics, and immunology.化脓性汗腺炎的最新进展:种族、遗传学和免疫学的作用
Front Genet. 2022 Aug 26;13:918858. doi: 10.3389/fgene.2022.918858. eCollection 2022.
10
Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard.日本化脓性汗腺炎患者生活质量的总体损害:与国家标准的比较。
Acta Derm Venereol. 2022 Jan 18;102:adv00632. doi: 10.2340/actadv.v101.1013.